Lee's Pharmaceutical Holdings Limited (HKG:0950)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.400
+0.060 (4.48%)
At close: Mar 10, 2026
6.06%
Market Cap 824.37M
Revenue (ttm) 1.44B
Net Income (ttm) 97.81M
Shares Out 588.84M
EPS (ttm) 0.17
PE Ratio 8.43
Forward PE n/a
Dividend 0.05 (3.51%)
Ex-Dividend Date Sep 12, 2025
Volume 747,000
Average Volume 684,860
Open 1.360
Previous Close 1.340
Day's Range 1.360 - 1.450
52-Week Range 1.190 - 2.700
Beta 0.50
RSI 44.28
Earnings Date Mar 27, 2026

About HKG:0950

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea... [Read more]

Sector Healthcare
Founded 1994
Employees 1,036
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0950
Full Company Profile

Financial Performance

In 2024, HKG:0950's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial Statements

News

There is no news available yet.